Sodium polystyrene sulfonate and Cellcept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sodium polystyrene sulfonate (sodium polystyrene sulfonate) and Cellcept (mycophenolate mofetil). Common drug interactions include arteriovenous fistula site complication among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Sodium polystyrene sulfonate and Cellcept. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Sodium polystyrene sulfonate?

Sodium polystyrene sulfonate has active ingredients of sodium polystyrene sulfonate. eHealthMe is studying from 1,667 Sodium polystyrene sulfonate users. Check the latest studies of Sodium polystyrene sulfonate.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

On Jul, 20, 2026

39 people who take Sodium polystyrene sulfonate and Cellcept together, and have interactions are studied.

Sodium polystyrene sulfonate and Cellcept drug interactions.

What are the common drug interactions of Sodium Polystyrene Sulfonate and Cellcept, by gender? *:

female:

Arteriovenous fistula site complication
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
Arteriovenous graft aneurysm
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Back pain
Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
Blood calcium decreased
Blood glucose decreased
Bone disorder
Change of bowel habit

male:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Respiratory failure (inadequate gas exchange by the respiratory system)
Blood pressure increased
Cough
Heart rate increased
Abdominal distension
Acidosis (build-up of carbon dioxide in the blood)
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)

What are the common drug interactions of Sodium Polystyrene Sulfonate and Cellcept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Kidney transplant rejection

20-29:

Blood pressure increased
Heart rate increased
Nausea (feeling of having an urge to vomit)
Pyrexia (fever)
Body temperature increased
Chills (felling of cold)
Fatigue (feeling of tiredness)
Feeling hot
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Chronic kidney disease

30-39:

Vomiting
Abdominal pain
Aortic valve incompetence
Aspergillus test positive
Blood lactate dehydrogenase increased
Cardiac failure acute
Cardiac valve vegetation (heart valve abnormal growth)
Catheter site haemorrhage (bleeding at catheter site)
Cytomegalovirus test positive
Depressed level of consciousness

40-49:

Dyspepsia (indigestion)
Abdominal pain upper
Acute leukaemia (blood cancer)
Anaemia (lack of blood)
Anxiety
Arteriovenous fistula site complication
Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
Arteriovenous graft aneurysm
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Back pain

50-59:

Decreased appetite
Decreased interest
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Dental caries
Depression
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
Device related infection
Diarrhoea
Discomfort
Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)

60+:

Diarrhoea
Bradycardia (abnormally slow heart action)
Cardiac arrest
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
Hyperhidrosis (abnormally increased sweating)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Insomnia (sleeplessness)
Lethargy (tiredness)
Lung transplant

What are the existing conditions these people have? *

Hyperkalemia (damage to or disease of the kidney): 11 people, 28.21%
High Blood Pressure: 3 people, 7.69%
Pain: 2 people, 5.13%
Chronic Kidney Disease: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium polystyrene sulfonate and Cellcept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously